Amarin Corp. Plc (AMRN)
Evaluation: Based on all recent filings, financial statements, and news.
See full evaluationAsk a question about Amarin Corp. Plc (AMRN)
Go deeper and ask any question about AMRN
Company Performance
Current Price
as of Sep 13, 2024$0.60
P/E Ratio
N/A
Market Cap
$246.7M
Description
Amarin Corp. Plc is a pharmaceutical company, which focuses on the commercialization and development of therapeutics for cardiovascular health. It focuses on the development and commercialization of Vascepa capsules. The company was founded by Geoffrey William Guy on March 1, 1989 and is headquartered in Dublin, Ireland.
Metrics
Overview
- HQDublin, DU
- SectorHealth Technology
- IndustryPharmaceuticals: Major
- TickerAMRN
- Price$0.6+3.13%
Trading Information
- Market Cap$246.70M
- Float99.61%
- Average Daily Volume (1m)630,858
- Average Daily Volume (3m)1,313,017
- EPS-$0.08
Company
- Revenue$265.09M
- Rev Growth (1yr)-15.99%
- Net Income$1.52M
- Gross Margin62.24%
- EBITDA Margin0.35%
- EBITDA$0.24M
- EV-$16.05M
- EV/Revenue-0.06
- P/EN/A
- P/S0.93
Documents
SEC Filings
Factset Street Account
Earnings Calls
Factset